omega-n-methylarginine has been researched along with temocaprilat in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (temocaprilat) | Trials (temocaprilat) | Recent Studies (post-2010) (temocaprilat) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 29 | 4 | 1 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | temocaprilat (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.0036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, N; Manabe, H; Matsumoto, N; Naito, Y; Ochiai, J; Oka, S; Takagi, T; Uemura, M; Yoshida, N; Yoshikawa, T | 1 |
1 other study(ies) available for omega-n-methylarginine and temocaprilat
| Article | Year |
|---|---|
An AT1-receptor antagonist and an angiotensin-converting enzyme inhibitor protect against hypoxia-induced apoptosis in human aortic endothelial cells through upregulation of endothelial cell nitric oxide synthase activity.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Aorta; Apoptosis; Benzimidazoles; Biphenyl Compounds; Bradykinin; Caspase 3; Caspases; Cell Hypoxia; Cells, Cultured; Endothelium, Vascular; Humans; Imidazoles; Necrosis; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Pyridines; Tetrazoles; Thiazepines | 2003 |